Learning interpretable disease self-representations for drug repositioning

by   Fabrizio Frasca, et al.

Drug repositioning is an attractive cost-efficient strategy for the development of treatments for human diseases. Here, we propose an interpretable model that learns disease self-representations for drug repositioning. Our self-representation model represents each disease as a linear combination of a few other diseases. We enforce the proximity between diseases to preserve the geometric structure of the human phenome network - a domain-specific knowledge that naturally adds relational inductive bias to the disease self-representations. We prove that our method is globally optimal and show results outperforming state-of-the-art drug repositioning approaches. We further show that the disease self-representations are biologically interpretable.


page 1

page 2

page 3

page 4

page 6

page 7

page 8

page 9


Deep learning for drug repurposing: methods, databases, and applications

Drug development is time-consuming and expensive. Repurposing existing d...

Clinical connectivity map for drug repurposing: using laboratory tests to bridge drugs and diseases

Drug repurposing has attracted increasing attention from both the pharma...

Modeling Pharmacological Effects with Multi-Relation Unsupervised Graph Embedding

A pharmacological effect of a drug on cells, organs and systems refers t...

Ontology Based Information Extraction for Disease Intelligence

Disease Intelligence (DI) is based on the acquisition and aggregation of...

Interpretable ICD Code Embeddings with Self- and Mutual-Attention Mechanisms

We propose a novel and interpretable embedding method to represent the i...

Network-principled deep generative models for designing drug combinations as graph sets

Combination therapy has shown to improve therapeutic efficacy while redu...

Measuring Adverse Drug Effects on Multimorbity using Tractable Bayesian Networks

Managing patients with multimorbidity often results in polypharmacy: the...